Ono Digital Health Investment, GK

Overview

Ono Digital Health Investment, GK is a corporate venture capital firm established by Ono Pharmaceutical Co., Ltd. in March 2022. The firm focuses on investing in venture companies within the healthcare sector, excluding ethical pharmaceutical drug-related fields. Its mission is to create new value in healthcare by collaborating with innovative startups that utilize digital technology to address health-related social issues, such as disease prevention and quality of life improvement. The firm is committed to extending healthy life expectancy and realizing a sustainable society through these collaborations. The investment strategy of Ono Digital Health Investment encompasses a broad spectrum of healthcare-related industries, including digital health, artificial intelligence, medical devices, biotechnology, pharmaceuticals, medical imaging, diagnostics, telemedicine, health IT, wearable technology, health and wellness, medical software, health services, and medical equipment. The firm is open to investing in companies at various stages of development, from pre-seed to late stage, and across different geographical regions, including Japan, Taiwan, the United States, and Europe. This diverse approach allows the firm to support a wide range of innovative solutions in the healthcare sector. Since its inception, Ono Digital Health Investment has made strategic investments in several promising startups. Notably, in November 2022, the firm completed an investment in aetherAI Co., Ltd., a Taiwanese company specializing in AI-powered diagnostic support solutions. In November 2024, aetherAI was listed on the Taiwan Emerging Stock Board, highlighting the success and growth of the companies supported by Ono Digital Health Investment. The firm's proactive approach to open innovation and strategic investments underscores its commitment to advancing healthcare through digital transformation and collaboration with forward-thinking companies.

Investment Focus

• Innovative solutions addressing health-related social issues
• Utilization of digital technology in healthcare
• Potential for collaboration with Ono Pharmaceutical Co., Ltd. and its affiliates
• Commitment to extending healthy life expectancy and realizing a sustainable society

Portfolio Companies